On The Move (Company Changes and Promotions 06/11)
Executive Summary
Recent executive-level company changes and promotions in the biotech, pharmaceutical, and medical device industries.
ANDERES, Kenna, PhD
To:Molecular Response LLC, SVP, Translational Medicine (May)
From:Cylene Pharmaceuticals Inc., VP, Cancer Biology
Tel:858-622-2900
ARNOLD, Lyle, PhD
To:Biocept Inc., SVP, CSO (May)
From:Aegea Biotechnologies Inc., Founder & Director
Tel:858-320-8200
BECK, Douglas
To:iBio Inc., CFO (May)
From:Lev Pharmaceuticals Inc., CFO
Tel:302-355-0650
BENDER, Norbert, MD, PhD
To:Evolva SA, CMO (May)
From:Medical Consultant
Tel:+41 61 485 2000
BONFIGLIO, John N., PhD
To:Oragenics Inc., Pres. & CEO (May)
From:Transdel Phamaceuticals Inc., Pres. & CEO
Tel:386-418-4018
BUTITTA, Cynthia
To:NextWave Pharmaceuticals Inc., SVP, CFO (May)
From:Telik Inc., COO & CFO
Tel:408-342-1300
CALVARESE, Barry
To:PreCision Dermatology Inc., EVP, R&D, & CTO (May)
From:Dow Pharmaceutical Sciences Inc., VP, Clinical & Regulatory Affairs
Tel:888-713-8154
CZEREPAK, Elizabeth A.
To:Cancer Genetics Inc., CFO (May)
From:Bear, Sterns & Co., Managing Dir.
Tel:201-528-9200
DUNN, Michael
To:Biocept Inc., SVP, Corp. Dev. (May)
From:Consultant
Tel:858-320-8200
ECK, Stephen, MD, PhD
To:Astellas Pharma Global Development Inc., VP, Head, Medicinal Oncology (May)
From:Eli Lilly & Co., VP, Translational Medicine & Pharmacogenomics
Tel:800-695-4321
EISENBUD, David E., MD
To:CoDa Therapeutics Inc., CMO (May)
From:Overlook Hospital Wound Healing Program, Medical Dir.
Tel:858-677-0474
ELIZONDO, David R.
To:Direct Flow Medical Inc., Chief Dev. Officer (May)
From:ATS Medical Inc., VP, R&D, & General Mgr., Tissue Valve Ops.
Tel:707-576-0420
FORBES-MCKEAN, Kimberley, PhD
To:Aqua Pharmaceuticals LLC, VP, R&D (May)
From:Cutanea Life Sciences Inc., EVP, CSO
Tel:610-644-7000
FORD, Rodger
To:MicroMed Cardiovascular Inc., Chmn. & CEO (May)
From:SynCardia Systems Inc., Pres. & CEO
Tel:713-839-9210
GARMEY, Edward, MD
To:Cerulean Pharma Inc., SVP, CMO (May)
From:ArQule Inc., VP, Clinical Dev.
Tel:617-551-9600
GLASSELL, Claes
To:CMS Biologics Inc., CEO (May)
From:Cerus Corp., CEO
Tel:425-485-1900
HALLER, Michael F., PhD
To:Anaphore Inc., SVP, Strategic Parternships (May)
From:Halozyme Therapeutics Inc., VP, Alliance Mgmt. & Portfolio Dev.
Tel:858-587-4815
ISHRAK, Omar, PhD
To:Medtronic Inc., Chmn. & CEO (June)
From:GE Healthcare Systems, Pres. & CEO
Tel:763-514-4000
JOHNSON, James A.
To:Relypsa Inc., SVP, CFO (May)
From:ZymoGenetics Inc., EVP, CFO
Tel:408-200-9500
JOHNSTON, Thomas
To:Mucosis BV, CBO (May)
From:Novavax Inc., VP, Strategy
Tel:+31 50 82000 50
JONES, Richard
To:Shield Therapeutics AG, CFO (May)
From:Brewin Dolphin Investment Banking, Dir. & Head, Healthcare
Tel:+44 1932 268436
KENNY, Kevin J.
To:Cardiovascular Systems Inc., EVP, Sales & Mktg. (May)
From:Medtronic Inc., Exec. Consultant, Special Projects, Medtronic Spine & Biologics
Tel:877-274-0360
LOGAN, H. Casey
To:Anaphore Inc., SVP, Bus. Dev. (May)
From:Anadys Pharmaceuticals Inc., Senior Dir., Head, Corp. Dev.
Tel:858-587-4815
LYTTON, Michael
To:Patheon Inc., EVP, Corp. Dev. & Strategy, & General Counsel (May)
From:Biogen Idec Inc., EVP, Corp. & Bus. Dev.
Tel:919-226-3200
MACKAY, Keith
To:BioLeap LLC, VP, Sales (May)
From:GVK Biosciencs Inc., VP, Sales & Mktg.
Tel:215-371-2874
MAPES, Harold C.
To:Delcath Systems Inc., EVP, Global Operations (May)
From:AngioDynamics Inc., SVP, Operations
Tel:212-489-2100
MARTIN, David C., PhD
To:Novadaq Technologies Inc., VP, Bus. Dev. & Investor Relations (May)
From:Dundee Securities, Healthcare Analyst
Tel:905-629-3822
MARTIN, Kip
To:Columbia Laboratories Inc., VP, Bus. Dev. (May)
From:Consultant
Tel:866-566-5636
MCCARTHY, Shawn P.
To:Tryton Medical Inc., Pres. & CEO (May)
From:AngioDynamics Inc., SVP, General Mgr., Vascular & Oncology Surgery
Tel:919-226-1490
MCREYNOLDS, Cristopher
To:Alverix Inc., VP, Bus. Dev. (May)
From:Satoris Inc., CEO
Tel:408-432-8372
MULLEN, Michael J.
To:Rapid Microbiosystems Inc., CFO (May)
From:Valeritas Inc., Interim CFO
Tel:781-271-1444
MURPHY, Robert J.
To:NuPathe Inc., VP, Sales (May)
From:Pfizer Inc., SVP, Hospital & Surgical Products
Tel:484-567-0130
PANGRATZ, Christian M.
To:Activaero GMBH, CBO (May)
From:Nektar Therapeutics Inc., Exec. Dir., Bus. Dev.
Tel:+49 6453 648180
PARSLEY, Ed
To:Aires Pharmaceuticals Inc., CMO (May)
From:Pfizer Inc., Clinical Lead, Revatio
Tel:858-366-9670
PELLINI, Michael J., MD
To:Foundation Medicine Inc., Pres. & CEO (May)
From:Clarient Inc., Pres. & COO
Tel:617-418-2200
RAUTSOLA, Riku, PhD
To:Laurantis Pharma Oy, Pres. & CEO (May)
From:Virxsys Corp., Pres. & CEO
Tel:+358 2 4788 378
REEVES, Karen, MD
To:Astellas Pharma Gobal Development Inc., VP, Global Head, Medicinal Science (May)
From:Medivation Inc., SVP, Clinical Dev.
Tel:800-695-4321
RUIZ, Nancy, MD
To:Optimer Pharmaceuticals Inc., SVP, R&D (May)
From:Merck Research Laboratories, VP, Project & Pipeline Mgmt., Infectious Diseases
Tel:858-909-0736
SCHWALM, Cynthia
To:Optimer Pharmaceuticals Inc., SVP, International (May)
From:Eisai Pharmaceuticals Inc., Pres.
Tel:858-909-0736
SHORES, Clyde W.
To:Cytori Therapeutics Inc., EVP, Mktg. & Sales (May)
From:Baxter International Inc., VP, Global Mktg., Renal
Tel:858-458-0900
SORENSEN, Gregory, MD
To:Siemens Healthcare US, CEO (June)
From:Massachusetts General Hospital, Co-director, Martinos Center for Biomedical Imaging
Tel:610-408-0121
TULLMAN, Steve
To:Yaupon Therapeutics Inc., Chmn. & CEO (May)
From:Vicept Therapeutics Inc., Chmn.
Tel:610-975-9290
VERNIMB, Jeff
To:Insight Pharmaceuticals Corp., VP, Sales (May)
From:Dynova Laboratories, VP, Mktg. & Sales
Tel:267-852-0505
WATSON, Andy
To:RainDance Technologies Inc., VP, Chief Mktg. Officer (May)
From:Life Technologies Corp., VP, SOLiD Sequencing Product Mgmt.
Tel:781-861-6300
WAYNE, Jeff
To:PreCision Dermatology Inc., VP, General Mgr., Onset Dermatologics (May)
From:Promius Pharma LLC, SVP, Sales & Mktg.
Tel:888-713-8154
WOLF, Rob
To:Angeion Corp., CFO (May)
From:Rimage Corp., CFO
Tel:612-315-2000
ZEIHER, Bernhardt, MD
To:Astellas Pharma Global Development Inc., VP, Therapeutic Area Leader, Inflammation, Immunology, & Infectious Diseases (May)
From:Pfizer Inc., VP, Inflammation/Immunology Therapeutic Area
Tel:800-695-4321
BRAGA, Damian A.
To:Sanofi Pasteur
New Title:SVP, Commercial Operations, Vaccines (May)
Previous Title:Pres., Sanofi Pasteur US & VP, Sanofi Pasteur Americas
Tel:570-839-7187
BEHRS, Melissa Kelly
To:Geron Corp.
New Title:SVP, Strategic Portfolio Mgmt. (May)
Previous Title:VP, Corp. Dev. & SVP, Therapeutic Dev., Oncology
Tel:650-473-7700
GARIPPA, Michael
To:SynCardia Systems Inc.
New Title:Pres. & CEO (May)
Previous Title:Pres.
Tel:520-545-1234
GENTILE, Tom
To:GE Healthcare
New Title:Pres. & CEO, Healthcare Systems (May)
Previous Title:GE Aviation, VP, Services
Tel:800-345-2700
HANGAUER, David, PhD
To:Kinex Pharmaceuticals LLC
New Title:CSO (May)
Previous Title:SVP, Research
Tel:716-881-8972
HARRINGTON, Stephanie A. S.
To:Frantz Medical Group
New Title:COO (May)
Previous Title:VP, Research & Bus. Dev.
Tel:440-255-1155
KELSEY, Stephen, MD
To:Geron Corp.
New Title:EVP, Head, R&D, & CMO (May)
Previous Title:EVP, CMO, Oncology
Tel:650-473-7700
LAU, Johnson, MD, PhD
To:Kinex Pharmaceuticals LLC
New Title:CEO (May)
Previous Title:Chmn.
Tel:716-881-8972
LINGELBACH, Thomas
To:Intercell AG
New Title:CEO (May)
Previous Title:COO
Tel:+43 120620
SAYER, Kevin
To:DexCom Inc.
New Title:Pres. (June)
Previous Title:Chmn., Audit Committee
Tel:858-200-0200
SWINFORD, Michael J.
To:GE Healthcare
New Title:Pres. & CEO, Global Services (May)
Previous Title:General Mgr., Americas Services
Tel:800-345-2700
WANTANABE, Karl
To:Olympus Corp. of the Americas
New Title:Pres., Corporate (May)
Previous Title:EVP, CFO
Tel:484-896-5000
WOODFORD, Michael C.
To:Olympus Corp. of the Americas
New Title:Chmn. & CEO (May)
Previous Title:Pres. & COO
Tel:484-896-5000
Resignations
ARKOWITZ, David
From:AMAG Pharmaceuticals Inc., EVP, CFO & CBO (June)
Tel:617-498-3300
COOPER, Fred W.
From:Usana Health Sciences Inc., Pres. & COO (May)
Tel:801-954-7100
FIROUZ, Fereydoun
From:EMD Serono Inc., Pres. & CEO (May)
Tel:781-982-9000
LINDGREN, Fredrik
From:Karo Bio AB, CEO (May)
Tel:+46 86 08 6000
SMITH, Philip I.
From:Angeion Corp., CEO (May)
Tel:612-315-2000
WILSON, Mark H.
From:Usana Health Sciences Inc., EVP, Sales (May)
Tel:801-954-7100
WINSTEAD, Dwight
From:CareFusion Corp., COO (June)
Tel:858-617-2000
YATES, Jeffrey A.
From:Usana Health Sciences Inc., CFO (May)
Tel:801-954-7100